|
ZNF512B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62547753035369E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.09432512735475E-14 |
| Normal-vs-Stage2 |
1.643370E-04 |
| Normal-vs-Stage3 |
3.79474229816879E-13 |
| Normal-vs-Stage4 |
2.32419972157061E-10 |
| Stage1-vs-Stage2 |
4.537800E-02 |
| Stage1-vs-Stage3 |
3.360600E-01 |
| Stage1-vs-Stage4 |
2.127400E-01 |
| Stage2-vs-Stage3 |
1.328350E-02 |
| Stage2-vs-Stage4 |
1.488470E-02 |
| Stage3-vs-Stage4 |
6.140400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.1094237467878E-15 |
| Normal-vs-AfricanAmerican |
2.435500E-04 |
| Normal-vs-Asian |
5.03149999997454E-07 |
| Caucasian-vs-AfricanAmerican |
3.213000E-01 |
| Caucasian-vs-Asian |
2.205600E-01 |
| AfricanAmerican-vs-Asian |
9.358600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.17550000236599E-09 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
4.580800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.72972747236599E-12 |
| Normal-vs-Age(41-60Yrs) |
3.50197648657513E-12 |
| Normal-vs-Age(61-80Yrs) |
2.47349996040924E-09 |
| Normal-vs-Age(81-100Yrs) |
7.980600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.822600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.634400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.000800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.746400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.412800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.848600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.13269999730315E-08 |
| Classical-VS-Follicular |
8.087900E-02 |
| Classical-VS-Other |
3.036000E-01 |
| Classical-VS-Normal |
4.66290006606584E-10 |
| Tall-VS-Follicular |
1.79189999949259E-07 |
| Tall-VS-Other |
4.173000E-01 |
| Tall-VS-Normal |
1.62503344114384E-12 |
| Follicular-VS-Other |
1.980580E-01 |
| Follicular-VS-Normal |
2.33479999999231E-05 |
| Other-VS-Normal |
6.181600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.26050281323842E-11 |
| Normal-vs-N1 |
1.00090002952413E-09 |
| N0-vs-N1 |
1.489240E-01 |
|
|
